Prostate-specific antigen screening resulted in 13% lower prostate cancer mortality over a median 23 years of follow-up.
Prostate-cancer screening based on prostate-specific antigen (PSA) levels in the blood was introduced—and readily adopted—in the United States around the late 1980s. But this screening method, in ...
MedPage Today on MSN
PSA Screening Reduces Prostate Cancer Deaths, Long-Term Data Show
A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term follow-up results from the European Randomized Study of Screening for ...
Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...
Source: Getty Images Investigators report findings from an analysis of 20-year follow-up data from the ERSPC. Men who consistently avoid prostate cancer screening appointments face a ...
Share on Pinterest A new study found that 1 in 6 males skipped all of their prostate cancer screening appointments, leading to a 45% higher risk of death from the disease. pcess609/Getty Images Men ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results